U.S. Life Sciences Stock News

Wondering what to make of Veeva Systems stock right now? You are not alone. If you have been watching Veeva over the last year, you have seen some eye-catching numbers. The stock has climbed more than 43% in the past 12 months, with much of that growth accelerating in the past quarter. Investors who have stuck with Veeva saw a 21% jump over just the last 90 days, showing that momentum is strong, even after some dips earlier this year. So what is driving these moves? Part of it is Veeva’s...

Earlier this month, Schrödinger, Inc. announced it has ended the clinical development program for SGR-2921, its CDC7 inhibitor, following two patient deaths linked to the drug in a Phase 1 trial for acute myeloid leukemia and high-risk myelodysplastic syndromes. Although preclinical and early trial data suggested potential, Schrödinger determined further development would be too challenging due to emerging safety concerns. We’ll examine how the discontinuation of SGR-2921 due to safety...

ConocoPhillips Skandinavia AS recently awarded Halliburton a major five-year contract for comprehensive well stimulation services, including the transformation of the North Pomor vessel in the North Sea and implementation of Octiv digital fracturing technology. This contract highlights Halliburton's technological strengths in offshore stimulation and its ability to deliver integrated solutions for complex international projects. We'll now explore how this significant contract win supports...

If you are watching Madison Square Garden Sports (MSGS) after its latest earnings announcement, you are not alone. The company just posted results that showed a sharp downturn from last year. There was a swing from quarterly and full-year profits to losses, which caught investor attention. Sales dipped year-over-year and basic earnings per share numbers moved into negative territory, sparking plenty of discussion over what is next for MSGS stockholders. Zooming out, this comes at a time when...

Analog Devices ( NASDAQ:ADI ) Third Quarter 2025 Results Key Financial Results Revenue: US$2.88b (up 25% from 3Q 2024...

La-Z-Boy Incorporated recently reported first-quarter fiscal 2026 results, with sales of US$492.23 million and net income of US$18.2 million, marking year-over-year declines alongside reduced guidance for the next quarter. Management attributed the softer performance to uneven consumer demand and challenging macroeconomic conditions, while also announcing the acquisition of a 15-store network in the Southeast region as part of its Century Vision growth strategy. We'll explore how La-Z-Boy's...

DLocal recently reported second-quarter and first-half 2025 earnings with revenue for the quarter rising to US$256.46 million and the company updating full-year guidance to anticipate 30%-40% annual growth, while also announcing the appointment of Guillermo López Pérez as Chief Financial Officer. The combination of robust revenue figures, improved multi-period profitability, and top leadership changes highlights a period of strong operational progress and ongoing focus on governance at...

Trying to decide what to do with Martin Marietta Materials stock? You are not alone. Whether you have been following the aggregates giant for years or are just now giving MLM a closer look, its price movements this year make it a hot topic for investors focused on growth and value. This stock has been far from stagnant. Over the past year, it has delivered a total return of 11.4%, with notable momentum in just the past month, up 5.2%. Even more impressive, its five-year return tops 197%,...

Dynavax Technologies (DVAX) just shook up the vaccine landscape with positive topline data from its initial Phase 1/2 trial of Z-1018, a new shingles vaccine candidate. The headline here is parity: Z-1018 generated immune responses similar to Shingrix, the leading shingles shot, but with fewer moderate or severe side effects. With plans to kick off studies in older adults soon, the company is signaling confidence in its pipeline and putting itself in direct competition with established...

Opera (NasdaqGS:OPRA) just released its latest quarterly results, giving investors plenty to consider. Sales increased from last year, but net income was slightly lower, presenting a mixed picture at first glance. In addition to the earnings release, Opera raised its full-year revenue guidance and previewed a third quarter with double-digit growth. This suggests management is confident about the outlook for the rest of the year. The market often pays attention when companies not only meet but...

If you’ve been watching MPLX (MPLX), you’re probably noticing a subtle uptick in attention as the stock sits near its all-time highs with little headline news to drive it. Sometimes, a calm market move raises even more questions. Could steady performance signal confidence in MPLX’s outlook, or are investors simply waiting for the next catalyst? Either way, small gains in the background can often say as much as a dramatic headline moment. Over the past year, MPLX shares have delivered a 29%...

If you are looking at Southern’s latest share price and wondering whether now is the moment to act, you are not alone. The company’s stock has moved around quite a bit in recent months, offering both optimism and a bit of intrigue for investors considering their next steps. Over the past quarter, Southern has risen about 5.6%, and if you zoom out further, this year’s total return is comfortably above 15%, with a 119% return over the last five years. Not many utility companies can claim that...

If you are on the fence about what to do with Walt Disney stock, you are far from alone. The last year has been a bit of a rollercoaster for DIS, but the ride may be more about what lies ahead than what is in the rearview mirror. Disney’s share price has climbed more than 30% over the past year, outpacing the broader market and sparking optimism about a turnaround. Still, that short-term boost follows a far less inspiring three-year picture and a negative five-year return. This serves as a...

Earlier this week, Daiichi Sankyo and Merck announced that ifinatamab deruxtecan received Breakthrough Therapy Designation from the U.S. FDA for adults with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy, based on promising early clinical data. This marks the first Breakthrough Therapy Designation for ifinatamab deruxtecan, accelerating its development and highlighting its potential to address an unmet need in oncology. Now, we’ll consider how...

The analysts might have been a bit too bullish on ZIM Integrated Shipping Services Ltd. ( NYSE:ZIM ), given that the...

Tootsie Roll Industries, Inc. recently reported its earnings for the second quarter and six months ended June 30, 2025, showing revenue of US$155.09 million and net income of US$17.54 million for the quarter. Despite mixed sales and revenue results, the company achieved higher year-over-year net income and earnings per share, pointing to improved profitability. We'll now examine how Tootsie Roll Industries' stronger earnings and profitability shape the company's broader investment...

China Airlines recently announced it has taken delivery of two additional new Airbus A321-200neo aircraft from Air Lease Corporation, marking the seventh and eighth A321neo aircraft delivered to the Taiwanese carrier under a long-term lease agreement. This further demonstrates consistent demand for modern, fuel-efficient aircraft as airline customers accelerate their fleet expansion and renewal plans in response to global travel growth. We'll explore how Air Lease's successful A321neo...

Realty Income (NYSE:O) just slipped half a percent in the most recent trading session, a move that might catch the eye of any investor following this popular real estate stock. While there was no major headline behind today’s dip, Realty Income’s price action often sparks debate about whether investors are growing cautious or simply taking a breather after recent gains. For many who rely on its reputation as a dependable income generator, even minor shifts can be reason enough to take a...

Helmerich & Payne recently reported resilient third-quarter margins in North American Services, early signs of international market stabilization, and better-than-expected fourth quarter guidance, while the company’s VP and CAO sold 6,700 shares. Successful cost synergies from the KCA integration, particularly in Saudi Arabia, are helping offset challenges from a lower North American rig count and rig suspensions abroad. We'll explore how improving North American margins and international...

Trying to decide what to do with Intuitive Machines stock? You are not alone. There has been a lot of buzz around this name after its eye-catching run in the past year, and naturally, investors are wondering if the story still has room to run. Over the past twelve months, LUNR’s share price climbed over 62%. However, if you zoom in, the picture is a little less rosy, with a more than 23% pullback in the last month and a dramatic drop of nearly 55% year-to-date. That combination creates both...

Option Care Health, Inc. announced that Meenal Sethna, a highly experienced public company executive, will join as Chief Financial Officer effective October 1, 2025, succeeding Mike Shapiro, who will transition to a Strategic Advisor role after a decade as CFO. Sethna’s extensive cross-industry background and track record in finance, technology, and operational leadership may shape the company’s future financial strategy and resource allocation decisions. We'll explore how the upcoming CFO...

Earlier this week, Kraton Corporation announced new agreements with International Paper to ensure uninterrupted site services for its Savannah, Georgia facility, while International Paper also revealed plans to convert the No. 16 paper machine at its Riverdale mill in Alabama to containerboard production by late 2026. The partnership between Kraton and International Paper highlights a joint focus on stable supply chains in pine chemicals, while the mill conversion reflects a move toward...

It's been a good week for Jack Henry & Associates, Inc. ( NASDAQ:JKHY ) shareholders, because the company has just...

If you’ve been tracking Moody's (MCO) lately, you might have noticed the share price drifting in recent sessions, dipping by about 1% yesterday and giving back a bit more over the past week. While there is no single headline to blame, these fluctuations are drawing attention, especially as investors weigh whether this stretch is just the market catching its breath or the start of something bigger for one of the most important names in financial analytics. Looking at the bigger picture,...